Key facts
- GeodAlsics’s last known valuation is $20.7M (Jul 2025).
- It has raised $6.2M; the latest was Early Stage VC ($5.8M) in Jul 2025.
- Notable investors include The Vidi Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for GeodAlsics
- ·The full record, as it builds
Funding rounds
No funding rounds for GeodAlsics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GeodAlsics
Developer of a medtech company intended to offer AI-based clinical decision support modules. The company's platform leverages generative manifold learning technology to analyze patient health data comprehensively, facilitating personalized diagnosis and treatment recommendations, enabling researchers to advance their understanding of medical conditions and improve patient outcomes.
- Sector
- Healthcare
- HQ
- Grenoble, France
- Founded
- 2021
- Employees
- 7
- Website
- geodaisics.com/
- Ownership
- Privately Held (backing)
GeodAlsics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GeodAlsics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GeodAlsics in its N-PORT filings yet. We sweep new filings monthly.